Advanced search
Publication Cover
Toxicology Communications Volume 2, 2018 - Issue 1
Submit an article Journal homepage
1,177
Views
12
CrossRef citations to date
0
Altmetric
Rapid Communication

Treatment for long acting anticoagulant rodenticide poisoning – beyond INR monitoring?

Israel RubinsteinUniversity of Illinois, Chicago, IL, USA; ;Jesse Brown VA Medical Center, Chicago, IL, USA; View further author information
,
Guy WeinbergUniversity of Illinois, Chicago, IL, USA; ;Jesse Brown VA Medical Center, Chicago, IL, USA; View further author information
,
Richard van BreemenLinus Pauling Institute, Oregon State University, Corvallis, OR, USAView further author information
,
Ronald C. HershowUniversity of Illinois, Chicago, IL, USA; View further author information
&
Douglas L. FeinsteinUniversity of Illinois, Chicago, IL, USA; ;Jesse Brown VA Medical Center, Chicago, IL, USA; Correspondence[email protected]
View further author information
Pages 59-61 | Received 11 Jun 2018, Accepted 10 Jul 2018, Published online: 13 Aug 2018

References

  • King N, Tran MH. Long-acting anticoagulant rodenticide (Superwarfarin) poisoning: a review of its historical development, epidemiology, and clinical management. Transfus Med Rev. 2015;29(4):250–258.
  • Illinois Department of Public Health (IDPH). 2018. [cited 2018 Jul 27]. Available from: http://www.dph.illinois.gov/search/site/synthetic%20cannabinoids.
  • Ware KM, Feinstein DL, Rubinstein I, et al. Brodifacoum induces early hemoglobinuria and late hematuria in rats: novel rapid biomarkers of poisoning. Am J Nephrol. 2015;41(4–5):392–399.
  • Kalinin S, Marangoni N, Kowal K, et al. The long-lasting rodenticide brodifacoum induces neuropathology in adult male rats. Toxicol Sci. 2017;159(1):224–237.
  • Marangoni MN, Martynowycz MW, Kuzmenko I, et al. Membrane cholesterol modulates superwarfarin toxicity. Biophys J. 2016;110(8):1777–1788.
  • Bruno GR, Howland MA, McMeeking A, et al. Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing. Anna Emerg Med. 2000;36(3):262–267.
  • Hollinger BR, Pastoor TP. Case management and plasma half-life in a case of brodifacoum poisoning. Arch Intern Med. 1993;153(16):1925–1928.
  • Travis SF, Warfield W, Greenbaum BH, et al. Spontaneous hemorrhage associated with accidental brodifacoum poisoning in a child. J Pediatr. 1993;122(6):982–984.
  • Gunja N, Coggins A, Bidny S. Management of intentional superwarfarin poisoning with long-term vitamin K and brodifacoum levels. Clin Toxicol. 2011;49(5):385–390.
  • Olmos V, Lopez CM. Brodifacoum poisoning with toxicokinetic data. Clin Toxicol. 2007;45(5):487–489.
  • Underwood EL, Sutton J, Ellis IK, et al. Prolonged coagulopathy after brodifacoum exposure. Am J Health Syst Pharm. 2014;71(8):639–642.
  • DeLoughery TG, Shatzel J. The superwarfarin chronicles. Am Soc Hematol Clin News. 2018. [cited 2018 Jul 27]. Available from: https://www.ashclinicalnews.org/perspectives/the-superwarfarin-chronicles/.
  • Babcock J, Hartman K, Pedersen A, et al. Rodenticide-induced coagulopathy in a young child. A case of Munchausen syndrome by proxy. Am J Pediatr Hematol Oncol. 1993 15(1):126–130.
  • Weitzel JN, Sadowski JA, Furie BC, et al. Surreptitious ingestion of a long-acting vitamin K antagonist/rodenticide, brodifacoum: clinical and metabolic studies of three cases. Blood. 1990;76(12):2555–2559.
  • Boettcher S, Wacker A, Moerike K, et al. Acquired coagulopathy caused by intoxication with the superwarfarin-type anticoagulant rodenticide flocoumafen. Eur J Haematol. 2011 86(2):173–175.
  • Laposata M, Van Cott EM, Lev MH. Case records of the Massachusetts General Hospital. Case 1-2007. A 40-year-old woman with epistaxis, hematemesis, and altered mental status. N Engl J Med. 2007; 356(2):174–182.
  • Lo VM, Ching CK, Chan AY, et al. Bromadiolone toxicokinetics: diagnosis and treatment implications. Clin Toxicol. 2008; 46(8):703–710.
  • Altay S, Cakmak HA, Boz GC, et al. Prolonged coagulopathy related to coumarin rodenticide in a young patient: superwarfarin poisoning. Cardiovasc J Afr. 2012;23(9):e9–e11.
  • Spahr JE, Maul JS, Rodgers GM. Superwarfarin poisoning: a report of two cases and review of the literature. Am J Hematol. 2007;82(7):656–660.
  • Kapadia P, Bona R. Acquired deficiency of vitamin K-dependent clotting factors due to brodifacoum ingestion. Conn Med. 2008;72(4):207–209.
  • Tsutaoka BT, Miller M, Fung SM, et al. Superwarfarin and glass ingestion with prolonged coagulopathy requiring high-dose vitamin K1 therapy. Pharmacotherapy. 2003;23(9):1186–1189.
  • Morgan BW, Tomaszewski C, Rotker I. Spontaneous hemoperitoneum from brodifacoum overdose. Am J Emerg Med. 1996;14(7):656–659.
  • Miller MA, Levy PD, Hile D. Rapid identification of surreptitious brodifacoum poisoning by analysis of vitamin K-dependent factor activity. Am J Emerg Med. 2006;24(3):383.
  • McCarthy PT, Cox AD, Harrington DJ, et al. Covert poisoning with difenacoum: clinical and toxicological observations. Human Exp Toxicol. 1997;16(3):166–170.
  • Pavlu J, Harrington DJ, Voong K, et al. Superwarfarin poisoning. Lancet. 2005;365(9459):628.
  • Watts RG, Castleberry RP, Sadowski JA. Accidental poisoning with a superwarfarin compound (brodifacoum) in a child. Pediatrics. 1990 86(6):883–887.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.